Keywords: eisai, e2012, enter, human, ph, ad, trials

Eisai's E2012 to enter human Ph I AD trials

Article | 15 May 2006

Print This

Eisai Medical Research, a US clinical research subsidiary of Japanese drugmaker Eisai, says it will initiate a Phase I clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in